A carregar...
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. To date, most patients with HCC are diagnosed at an advanced tumor stage, excluding them from potentially curative therapies (i.e., resection, liver transplantation, percutaneous ablation). Treatments with palliative...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6689804/ https://ncbi.nlm.nih.gov/pubmed/31413525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i29.3870 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|